These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 307370)

  • 1. Blood loss and bank blood requirement in coronary bypass surgery.
    Yeh T; Shelton L; Yeh TJ
    Ann Thorac Surg; 1978 Jul; 26(1):11-6. PubMed ID: 307370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations.
    Fish KJ; Sarnquist FH; van Steennis C; Mitchell RS; Hilberman M; Jamieson SW; Linet OI; Miller DC
    J Thorac Cardiovasc Surg; 1986 Mar; 91(3):436-42. PubMed ID: 3512919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: a prospective randomized study.
    Ascione R; Williams S; Lloyd CT; Sundaramoorthi T; Pitsis AA; Angelini GD
    J Thorac Cardiovasc Surg; 2001 Apr; 121(4):689-96. PubMed ID: 11279409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of pericardial blood processing with a cell-saving device on neurologic markers in elderly patients undergoing coronary artery bypass graft surgery.
    Carrier M; Denault A; Lavoie J; Perrault LP
    Ann Thorac Surg; 2006 Jul; 82(1):51-5. PubMed ID: 16798186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bloodless open heart surgery with atraumatic extracorporeal circulation.
    McKenzie FN; Heimbecker RO; Barnicoat KT; Robert A; Gergeley NF; Del Maestro R; Wall W
    Can Med Assoc J; 1975 May; 112(9):1073-7. PubMed ID: 1079162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting.
    Puskas JD; Williams WH; Duke PG; Staples JR; Glas KE; Marshall JJ; Leimbach M; Huber P; Garas S; Sammons BH; McCall SA; Petersen RJ; Bailey DE; Chu H; Mahoney EM; Weintraub WS; Guyton RA
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):797-808. PubMed ID: 12698142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of normothermic systemic perfusion during coronary artery bypass operations: a randomized prospective study.
    Birdi I; Regragui I; Izzat MB; Bryan AJ; Angelini GD
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):475-81. PubMed ID: 9305202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood product use in cardiac revascularization: comparison of on- and off-pump techniques.
    Nader ND; Khadra WZ; Reich NT; Bacon DR; Salerno TA; Panos AL
    Ann Thorac Surg; 1999 Nov; 68(5):1640-3. PubMed ID: 10585034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
    Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autotransfusion of red blood cell from cardiopulmonary bypass circuit blood after cardiac surgery].
    Lenkutis T; Veikutiene A; Raliene L; Surkus J
    Medicina (Kaunas); 2002; 38 Suppl 2():213-6. PubMed ID: 12560664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol).
    Bidstrup BP; Royston D; Sapsford RN; Taylor KM
    J Thorac Cardiovasc Surg; 1989 Mar; 97(3):364-72. PubMed ID: 2465457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for hemorrhage-related reexploration and blood transfusion after conventional versus coronary revascularization without cardiopulmonary bypass.
    Frankel TL; Stamou SC; Lowery RC; Kapetanakis EI; Hill PC; Haile E; Corso PJ
    Eur J Cardiothorac Surg; 2005 Mar; 27(3):494-500. PubMed ID: 15740962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tranexamic acid and autotransfusion in coronary artery bypass.
    Mehr-Aein A; Davoodi S; Madani-Civi M
    Asian Cardiovasc Thorac Ann; 2007 Jan; 15(1):49-53. PubMed ID: 17244923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of coronary artery bypass grafting with or without cardiopulmonary bypass in overweight patients.
    Ascione R; Reeves BC; Rees K; Angelini GD
    Circulation; 2002 Oct; 106(14):1764-70. PubMed ID: 12356627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass.
    Dial S; Delabays E; Albert M; Gonzalez A; Camarda J; Law A; Menzies D
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):654-61. PubMed ID: 16153909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional blood conservation techniques in 500 consecutive coronary artery bypass operations.
    Ovrum E; Holen EA; Abdelnoor M; Oystese R
    Ann Thorac Surg; 1991 Sep; 52(3):500-5. PubMed ID: 1898137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive blood conservation in coronary artery surgery: impact on patient care.
    LoCicero J; Massad M; Gandy K; Sanders JH; Hartz RS; Frederiksen JW; Michaelis LL
    J Cardiovasc Surg (Torino); 1990; 31(5):559-63. PubMed ID: 2229148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary revascularization with or without cardiopulmonary bypass in patients with preoperative nondialysis-dependent renal insufficiency.
    Ascione R; Nason G; Al-Ruzzeh S; Ko C; Ciulli F; Angelini GD
    Ann Thorac Surg; 2001 Dec; 72(6):2020-5. PubMed ID: 11789787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mini-dose pump-prime aprotinin inhibited enhanced fibrinolytic activity and reduced blood loss and transfusion requirements after coronary artery bypass surgery.
    Kunt AS; Darcin OT; Aydin S; Demir D; Selli C; Andac MH
    J Thromb Thrombolysis; 2005 Jun; 19(3):197-200. PubMed ID: 16082607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations.
    Ovrum E; Am Holen E; Abdelnoor M; Oystese R; Ringdal ML
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):78-83. PubMed ID: 8419712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.